EFFICACY AND SAFETY OF OBINUTUZUMAB + LENALIDOMIDE + ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.113-114
Main Authors: Morschhauser, F., Ghosh, N., Lossos, I., Palomba, M.L., Mehta, A., Casasnovas, O., Stevens, D., Chitra, S., Knapp, A., Nielsen, T., Oestergaard, M., Wenger, M., Salles, G.
Format: Article
Language:English
Subjects:
Immunotherapy
Lymphoma
Monoclonal antibodies
Targeted cancer therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.74_2629